Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital

Indian Journal of Nephrology

Volumn 19, Issue 2, 2009, Pages 62-67

  Jasuja, S ^a   Gupta, A ^a   Choudhry, R ^b   Kher, V ^c   Aggarwal, D ^a   Mishra, A ^a   Agarwal, M ^a   Sarin, A ^a   Mishra, M ^a   Raina, V ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

^b AHERF   (India)

^c Fortis Hospitals   (India)

Author keywords

Duration of dialysis; Hemodialysis; Hepatitis C; Polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; VIREMIA;

EID: 77953417336     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.53324     Document Type: Article

References (25)

1. Fabirizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, et al. Serologic survey for control of hepatitis C in hemodialysis patients: Third-generation assays and analysis of costs. Nephrol Dial Transplant 1997;12:298-303. (Pubitemid 27090983)
2. Courouce AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, et al. Hepatitis C virus (HCV) infection in hemodialysis patients: HCV-RNA and anti-HCV antibodies (third generation assays). Nephrol Dial Transplant 1995;10:234-239
3. Covic A, Lancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, et al. Hepatitis virus infection in hemodialysis patients from Moldavia. Nephrol Dial Transplant 1999;14:40-45 (Pubitemid 29041864)
4. Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 2001;29:262. (Pubitemid 32929631)
5. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2004;65:2335-2342 (Pubitemid 38670020)
6. Tokars J, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 1997. Semin Dial 2000;13:75-85.
7. Bush MP, Korelitz JJ, Kleinman SH, Lee SR, AuBuchon JP, Schreiber GB. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection: The Retrovirus Epidemiology Donor Study. Transfusion 1995;35:903-910
8. Fabrizi F, Poordad FF, Martin P. Diagnostic workup of hepatitis C and the patient on maintenance dialysis. Int J Artif Organs 2001;325:98. (Pubitemid 34168372)
9. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long term study of hepatitis C virus replication in non A, non B hepatitis. N Engl J Med 1991;325:98-104.
10. Weinstein T, Tur-Kaspa R, Chagnac A, Korzets A, Ori Y, Zevin D, et al. Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J 2001;3:174-177 (Pubitemid 32432964)
11. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-999 (Pubitemid 27186522)
12. Herrine SK, Michael B, Ma WL, Rossi S, Dunn SR, Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroentreol 2002;97:2619-2622
13. Saab S, Martin P, Brezina M, Gitrich G, Yee HF Jr. Serum alkaline aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis 2001;37:308-315 (Pubitemid 32116022)
14. dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ. Impact of dialysis room and reuse strategies on the incidence of hepatitis of hepatitis C virus infection in hemodialysis units. Nephrol Dial Transplant 1996;11:2017-2022
15. Stuyver L, Claeys H, Wyseur A, Van Arnhem W, De Beenhouwer H, Uytendaele S, et al. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int 1996;49:889-895 (Pubitemid 26093099)
16. Rais-Jajali G, Khajehdehi P. Anti-HCV seropositivity among haemodialysis patients of Iranian origin. Nephrol Dial Transplant 1999;14:2055-2056 (Pubitemid 29358928)
17. Brugnano R, Francisci D, Quintaliani G, Gaburri M, Nori G, Verdura C, et al. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: Evaluation of some risk factors. Nephron 1992;61:263-265
18. Vagelli G, Calabrese G, Guaschio R, Gonella M. Effect of HCV + patients isolation of HCV infection incidence in a dialysis unit. Nephrol Dial Transplant 1992;7:1070.
19. Jadoul M, Cornu C, van Yperselle De Strihou C; the Universities Cliniques StLuc (UCL) collaborative Group. Universal precautions prevent hepatitis C virus transmission: 54 month follow up of the Belgian multicenter study. Kidney Int 1998;53:1022-1025
20. Jadoul M, Cornu C, Van Ypersele de Strihou C; for the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 1993;44:1322-1326
21. Taal MW, van Zyl-Smit R. Hepatitis C virus infection in chronic hemodialysis patients-relationship to blood transfusions and dialyzer re-use. S Afr Med J 2000;90:621.
22. Centers for Disease Control and Prevention. Recommemdations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50:1-43.
23. Natov SN, Lau JY, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. Am J Kidney Dis 1998;31:920-927 (Pubitemid 28265186)
24. Donahue JG, Mu-oz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, et al. The declining risk of post transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-373
25. Cendoroglo Neto M, Draibe SA, Siva AE, Ferraz ML, Granato C, Pereira CA, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 1995;10:240-246